ArticleJournal of the National Cancer Institute2026
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.
Yashasvini Sampathkumar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.